Authors: EGGLESTON A WIGERINCK A HUIJGHEBAERT S DUBOIS D HAYCOX A

Citation: A. Eggleston et al., COST-EFFECTIVENESS OF TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE IN CLINICAL-PRACTICE - A CLINICAL DATABASE ANALYSIS, Gut, 42(1), 1998, pp. 13-16

Authors: TOUGAS G HWANG P PATERSON WG TURNBULL G BOIVIN M FEDORAK R EGGLESTON A

Citation: G. Tougas et al., DYSPEPTIC SYMPTOMS IN THE GENERAL CANADIAN POPULATION - PREVALENCE AND IMPACT ON QUALITY-OF-LIFE, Gastroenterology, 114(4), 1998, pp. 1275-1275

Authors: EGGLESTON A WIGERINCK A HAYCOX A

Citation: A. Eggleston et al., OUTCOME RESEARCH IN GORD - RETROSPECTIVE ANALYSIS OF PRESCRIPTION DATA (MEDIPLUS(R) UK) ON CISAPRIDE (CIS), RANITIDINE (RAN) AND OMEPRAZOLE(OME), Gastroenterology, 112(4), 1997, pp. 13-13

Authors: EGGLESTON A WIGERINCK A HAYCOX A

Citation: A. Eggleston et al., COST OF GORD-MEDICATION IN CLINICAL-PRACTICE IN PATIENTS WITH A FIRSTDIAGNOSIS OF GORD BASED ON PRESCRIPTION-DATA ANALYSIS (MEDIPLUS UK), Gastroenterology, 112(4), 1997, pp. 13-13

Authors: VANDOORSLAER EKA TORMANS G GUPTA AK VANROSSEM K EGGLESTON A DUBOIS DJ DEDONCKER P HANEKE E

Citation: Eka. Vandoorslaer et al., ECONOMIC-EVALUATION OF ANTIFUNGAL AGENTS IN THE TREATMENT OF TOENAIL ONYCHOMYCOSIS IN GERMANY, Dermatology, 193(3), 1996, pp. 239-244